EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
168 hedge funds and large institutions have $617M invested in Eagle Pharmaceuticals, Inc. in 2020 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 59 increasing their positions, 61 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
168
Holders Change
-8
Holders Change %
-4.55%
% of All Funds
3.71%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
18
Increased
59
Reduced
61
Closed
23
Calls
$795K
Puts
$3.59M
Net Calls
-$2.8M
Net Calls Change
-$13.2M
Top Buyers
Top Sellers
1 |
HEC
Hudson Executive Capital
New York
|
-$39.8M |
2 |
BlackRock
New York
|
-$6.29M |
3 |
Invesco
Atlanta,
Georgia
|
-$4.28M |
4 |
MCM
Matarin Capital Management
New York
|
-$3.76M |
5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$3.08M |